813 Mrv0541 02231215012D 25 27 0 0 0 0 999 V2000 1.6500 2.2688 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -0.2063 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 2.2688 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 1.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -1.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 2.6813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 2.6813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -2.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 3.5063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.7935 3.5063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 2.2688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 3.9188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -2.6813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 -2.6813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.5080 3.9188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2224 2.6813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.2224 3.5063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.0791 -3.5063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.6500 -3.5063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.3645 -3.9188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1 12 2 0 0 0 0 2 7 1 0 0 0 0 2 8 1 0 0 0 0 2 9 1 0 0 0 0 3 4 1 0 0 0 0 3 11 1 0 0 0 0 3 12 1 0 0 0 0 4 5 1 0 0 0 0 4 6 1 0 0 0 0 5 7 1 0 0 0 0 6 8 1 0 0 0 0 9 10 1 0 0 0 0 10 13 1 0 0 0 0 11 15 2 0 0 0 0 11 16 1 0 0 0 0 12 14 1 0 0 0 0 13 18 2 0 0 0 0 13 19 1 0 0 0 0 14 17 1 0 0 0 0 15 20 1 0 0 0 0 16 21 2 0 0 0 0 18 23 1 0 0 0 0 19 24 2 0 0 0 0 20 22 2 0 0 0 0 21 22 1 0 0 0 0 23 25 2 0 0 0 0 24 25 1 0 0 0 0 M END > DB00813 > drugbank > CCC(=O)N(C1CCN(CCC2=CC=CC=C2)CC1)C1=CC=CC=C1 > InChI=1S/C22H28N2O/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19/h3-12,21H,2,13-18H2,1H3 > PJMPHNIQZUBGLI-UHFFFAOYSA-N > C22H28N2O > 336.4705 > 336.220163528 > 2 > 53 > 0.9832107301672904 > 39.89292881337242 > 1 > 0 > 0 > 1 > N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide > 4.12 > 3.8154985483333332 > -4.15 > 1 > 1 > 3 > 1 > 8.767614789214603 > 23.550000000000004 > 103.48250000000004 > 6 > 1 > 2.40e-02 g/l > tetrahydrofolic acid > 1 > DB00813 > APRD00347; DB05853; DB06055; DB06220; DB05564 > approved; illicit; investigational; vet_approved > Fentanyl > 1-Phenethyl-4-(N-phenylpropionamido)piperidine; 1-phenethyl-4-N-propionylanilinopiperidine; Fentanil; Fentanila; Fentanilo; Fentanyl; Fentanyl CII; Fentanylum; N-(1-phenethyl-4-piperidinyl)-N-phenylpropionamide; N-(1-phenethyl-4-piperidyl)propionanilide; N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide; N-(1-phenethylpiperidin-4-yl)-N-phenylpropionamide; N-phenethyl-4-(N-propionylanilino)piperidine; N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide; Phentanyl > Abstral; Abstral fentanyl; Actiq; Apo-fentanyl Matrix; Co Fentanyl; DURAGESIC (fentanyl system); Duragesic; Duragesic 100; Duragesic 12; Duragesic 25; Duragesic 50; Duragesic 75; Effentora; FENTANYL TRANSDERMAL system; Fentanyl; Fentanyl - NOVAPLUS; Fentanyl Buccal; Fentanyl Citrate; Fentanyl Citrate Injection; Fentanyl Citrate Injection Sdz; Fentanyl Citrate Injection U.S.P.-liq IV Im Epd; Fentanyl Citrate Injection USP; Fentanyl Citrate Injection USP 50mcg/ml; Fentanyl Citrate Injection, USP; Fentanyl Citrate, Bupivacaine HCl; Fentanyl Injection BP; Fentanyl Patch; Fentanyl System; Fentanyl Transdermal; Fentanyl Transdermal System; Fentanyl Transdermal System 100; Fentanyl Transdermal System 25; Fentanyl Transdermal System 50; Fentanyl Transdermal System 75; Fentanyl system; Fentanyl transdermal system; Fentora; Innovar Inj; Instanyl; Ionsys; Lazanda; Mylan-fentanyl Matrix Patch; Onsolis; PMS-fentanyl Mtx; Pat-fentanyl Mat; Pecfent; Ran-fentanyl Matrix Patch; Ran-fentanyl Transdermal System; Sandoz Fentanyl Patch; Sublimaze; Sublimaze Inj 50mcg/ml; Subsys; Teva-fentanyl; Transmucosal Fentanyl Citrate > Durogesic; Fentanest; Nasalfent; Rapinyl > Fentanyl citrate; Fentanyl hydrochloride $$$$